Humana Analysts Slash Their Forecasts After Q4 Results
Portfolio Pulse from Avi Kapoor
Humana Inc. (NYSE:HUM) reported a Q4 adjusted loss of $0.11 per share, missing consensus estimates. Revenue was $25.73 billion, above the consensus of $25.55 billion. The company provided FY24 EPS guidance significantly below consensus, leading to a reduction in price targets by Goldman Sachs, RBC Capital, UBS, and Stephens & Co. Despite this, Humana shares rose 2.5%.
January 26, 2024 | 6:24 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Humana missed Q4 EPS estimates and issued weak FY24 guidance, leading analysts to lower price targets. However, the stock price increased by 2.5%.
Despite the negative earnings report and reduced guidance, Humana's stock price rose, indicating mixed market reactions. The short-term impact is neutral as the price increase suggests investor confidence, but analyst downgrades could create downward pressure.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100